Anlon Healthcare Ltd — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 — transcript filed; not yet summarisedQ4 FY26
Q4 FY26 earnings call
Anlon Healthcare reported FY26 consolidated total income of INR 172.22 crore, up 42.98% year-on-year, with EBITDA up 47.55% and PAT up 41.77%. Q4 FY26 total income was INR 50.90 crore versus INR 48.97 crore a year earlier, while reported PAT of INR 11.07 crore was lower than INR 16.65 crore in the year-ago quarter due to higher operating and development expenses. Management discussed the completed acquisitions of Apiqo Organics and Bizotic Life Science, capacity expansion plans, and provided revenue and margin outlook for FY27 and FY28.